bioAffinity Technologies, Inc. (BIAF)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Steven Girgenti | Founder & Executive Chairman of the Board | 115.43k | -- | 1946 |
| Ms. Maria Zannes J.D. | Founder, President, CEO & Director | 327.16k | -- | 1956 |
| Mr. Xavier T. Reveles M.S. | Chief Operating Officer | -- | -- | 1970 |
| Dr. William Bauta Ph.D. | Chief Science Officer | -- | -- | -- |
| Mr. Timothy P. Zannes J.D. | Executive VP, Secretary & General Counsel | -- | -- | 1953 |
| Ms. Julie Anne Overton | Director of Communications | -- | -- | -- |
| Mr. Dallas J. Coleman | Vice President of sales | -- | -- | -- |
bioAffinity Technologies, Inc.
- Sector:
- Healthcare
- Industry: Diagnostics & Research
- Full Time Employees:
- 57
Description
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Corporate Governance
Upcoming Events
May 13, 2025 at 8:00 PM UTC - May 19, 2025 at 8:00 PM UTC
bioAffinity Technologies, Inc. Earnings Date